Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (131-140 of 225) with videos related to

Pageof 23
Sort By:
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
International Journal of Immunogenetics|January 22, 2021
Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profilingCyril Dalmasso, Céline Derbois, Maëva Veyssiere, et al.
Arthritis Care & Research|February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
PLOS Digital Health|June 27, 2024
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseasesCécile Trottet, Ahmed Allam, Aron N Horvath, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2018
Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid ArthritisEva-Maria Didden, Yann Ruffieux, Noemi Hummel, et al.
Rheumatology (Oxford, England)|December 8, 2020
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseCéline Lamacchia, Zuleika Calderin Sollet, Delphine Courvoisier, et al.
BMJ Open|March 13, 2024
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RABenoit Thomas P Gilbert, Denis Mongin, Romain Aymon, et al.
Arthritis and Rheumatism|February 28, 2009
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritisGaby Palmer, Dominique Talabot-Ayer, Céline Lamacchia, et al.
RMD Open|December 4, 2021
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximabCathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, et al.
Arthritis and Rheumatism|December 31, 2005
The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based studyAxel Finckh, Julia F Simard, Jeffrey Duryea, et al.
Pageof 23

Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Arthritis Research & Therapy|May 8, 2020
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritisMatthias Jarlborg, Delphine S Courvoisier, Céline Lamacchia, et al.
International Journal of Immunogenetics|January 22, 2021
Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profilingCyril Dalmasso, Céline Derbois, Maëva Veyssiere, et al.
Arthritis Care & Research|February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
PLOS Digital Health|June 27, 2024
Explainable deep learning for disease activity prediction in chronic inflammatory joint diseasesCécile Trottet, Ahmed Allam, Aron N Horvath, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2018
Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid ArthritisEva-Maria Didden, Yann Ruffieux, Noemi Hummel, et al.
Rheumatology (Oxford, England)|December 8, 2020
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseCéline Lamacchia, Zuleika Calderin Sollet, Delphine Courvoisier, et al.
BMJ Open|March 13, 2024
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RABenoit Thomas P Gilbert, Denis Mongin, Romain Aymon, et al.
Arthritis and Rheumatism|February 28, 2009
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritisGaby Palmer, Dominique Talabot-Ayer, Céline Lamacchia, et al.
RMD Open|December 4, 2021
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximabCathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, et al.
Arthritis and Rheumatism|December 31, 2005
The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based studyAxel Finckh, Julia F Simard, Jeffrey Duryea, et al.
Pageof 23